Skip to main content
OpenTrials

Clinical trial condition

Duchenne Muscular Dystrophy

Explore clinical trials studying Duchenne Muscular Dystrophy. Study availability and eligibility vary by location and protocol.

216 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Duchenne Muscular Dystrophy trial results

Enrolling by invitation

A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice

NCT06606340

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
View all 20 locations
View Trial Details
Active, not recruiting

Open-label Extension of the HOPE-2 Trial

NCT04428476

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • University of California, Davis Sacramento, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Washington University St Louis, Missouri, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Active, not recruiting

A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

NCT06817382

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • USA012 Little Rock, Arkansas, United States
  • USA010 Davis, California, United States
  • USA009 Los Angeles, California, United States
  • USA002 Palo Alto, California, United States
View Trial Details
Active, not recruiting

NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

NCT05996003

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DMD, Duchenne Muscular Dystrophy, +10 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Rare Disease Research Atlanta, Georgia, United States
  • Ann and Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of Kansas Medical Center (KUMC) Kansas City, Kansas, United States
View all 29 locations
View Trial Details
Active, not recruiting

A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)

NCT06128564

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Chr de La Citadelle Liège, Belgium
  • Hôpital Necker-Enfants Malades Paris, France
  • Universitätsklinikum Essen Essen, Germany
  • PU A. Gemelli, Università Cattolica del Sacro Cuore Rome, Lazio, Italy
View Trial Details
Active, not recruiting

A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)

NCT06450639

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Fractures, Bone, +13 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of California Davis Medical Center Sacramento, California, United States
  • Children's Healthcare of Atlanta Center for Advanced Pediatrics Atlanta, Georgia, United States
  • Corewell Health Grand Rapids, Michigan, United States
View all 18 locations
View Trial Details

Related conditions